Science Mag: 'In Rare Cases, Coronavirus Vaccines May Cause Long Covid-Like Symptoms'Chris Menahan
Jan. 21, 2022
"It's Embarrassingly Hard to Get Google Gemini to Acknowledge That White People Exist"
Douglas Murray Announces New Doxing Database to Keep Critics of Israel From Getting a Job
Jon Stewart Tells Tucker Carlson America's Dangerous Subways Are 'The Literal Price Of Freedom'
Susan Wojcicki's Son, 19, Dies of Suspected Drug Overdose at UC Berkeley
CNN: Kremlin 'Has Never Been Richer'
Science magazine reported Thursday that "coronavirus vaccines may cause long covid-like symptoms," though they insist it's only "in rare cases."
John Travis, Managing Editor for News at Science, shared the article on Twitter while noting how "delicate" their reporting had to be.
From Science, "In rare cases, coronavirus vaccines may cause Long Covid–like symptoms":
[E]vidence from animal studies supports the idea that antibodies targeting the SARS-CoV-2 spike protein—the same protein that many vaccines use to trigger a protective immune response—might cause collateral damage, notes Harald Prüss, a neurologist at the German Center for Neurodegenerative Diseases (DZNE) and the Charité University Hospital in Berlin. In 2020, while hunting for antibody therapies for COVID-19, he and his colleagues discovered that of 18 antibodies they identified with potent effects against SARS-CoV-2, four also targeted healthy tissues in mice—a sign they could trigger autoimmune problems.Dr. Charles Hoffe said similar over six months ago and he got put under a gag order by the Canadian government and was widely demonized and censored for his trouble.
I guess he wasn't "delicate" enough seeing as how he claimed he saw microclots in 62% of the patients he gave D-dimer diagnostic tests to post-vax.
NIH apparently tried to help a few people with "postvaccine complications" but then abandoned them:
Over the first half of 2021, [Avindra Nath, clinical director at the National Institute of Neurological Disorders and Stroke] and [Farinaz Safavi, an NINDS neurologist] invited Brianne Dressen [an AstraZeneca vaccine clinical trial volunteer who developed "debilitating internal electric shocks," "heart rate fluctuations, severe muscle weakness" and other horrible side effects] and others to NIH for testing and, in some cases, short-term treatment, for example with high-dose steroids or intravenous immunoglobulin (IVIG), which can quell or modulate immune responses. The patients spent at least several days undergoing neurological, cardiac, and other tests, including lumbar punctures and skin biopsies.Here's video of Dressen sharing her testimony with Sen. Ron Johnson's panel on federal vaccine mandates in November:
For patients, the silence from NIH was distressing, especially as they struggled to find care elsewhere. The scientists "took the data and left us hanging," says a person who traveled to NIH in the spring of 2021. "I have no treatment, I have no idea what's happening to my body." Physicians, several patients said, had nothing to offer and sometimes even declared the symptoms imagined.NIH has over 20,000 employees and an annual budget exceeding $42 billion.
This is a massive bureaucracy filled with doctors dedicated to pushing experimental vaccines on the masses with zero long-term testing and they don't even have two people working full time on helping people suffering from debilitating side effects.
The NIH data, which documented the patient cases, haven't been reported yet. Two top medical journals declined to publish a case series of about 30 people, which Nath first submitted in March 2021. Nath says he understands the rejection. The data weren't "cut and dried; it was observational studies." This month, the scientists submitted a case series of 23 people to a third publication, and Nath says his group has submitted an amendment to a Long Covid protocol to include patients with postvaccine side effects.As I reported in October, Pfizer has a partnership with Google's sister company Verily to study the "long-term safety" of their shots but it doesn't even include a control group. They intentionally broke their control group in their clinical trial by giving them their mRNA shots so all long-term data would be useless.
Other researchers note the scientific community is uneasy about studying such effects. "Everyone is tiptoeing around it," Pretorius says. "I've talked to a lot of clinicians and researchers at various universities, and they don't want to touch it."The media doesn't want to touch it either and social media will ban those who do (if they're not from a major media outlet) for reporting on it...
Still, her group and others are pushing ahead. Prüss has detected autoantibodies in some patients with postvaccine symptoms, although not in others. Several groups are studying whether a patient's postvaccination symptoms are due to autoantibodies to the angiotensin-converting enzyme 2 (ACE2) receptor, which the spike protein targets. Cheng and her colleagues are planning a case series that includes sophisticated imaging and diagnostic tests from a mix of Long Covid patients and those with postvaccine side effects. And Pretorius and her colleague Chantelle Venter are hoping to recruit at least 50 people to study clotting patterns before and after vaccination.There's the "delicacy" Travis mentioned (there's a lot more of it in the full article).
Some of the patients who spoke with Science say medications that tamp down the immune system have offered at least a measure of relief. Nath noticed the same phenomenon. He hopes results from an NIH clinical trial testing IVIG and intravenous steroids in Long Covid patients "will be applicable to the vaccine-related complications." None of the patients with whom Science spoke has fully recovered.The US government reportedly spent "between $18 billion and $23 billion" to develop these covid shots at "Warp Speed."
Those who report they were injured by them are struggling to find even one US government doctor to treat them.
When the worm turns -- and it's already turning -- we need tribunals.
Follow InformationLiberation on Twitter, Facebook, Gab, Minds, Parler and Telegram.